Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : TDI-11055
CAS No.: 3057216-63-1
Catalog No.: PC-49300Not For Human Use, Lab Use Only.
TDI-11055 (TDI 11055) is a potent, selective and orally bioavailable inhibitor of the acyl-lysine reader ENL/AF9 YEATS domain with IC50 of 0.05 and 0.07 uM, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $218 | In stock | |
| 10 mg | $358 | In stock | |
| 25 mg | $548 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TDI-11055 (TDI 11055) is a potent, selective and orally bioavailable inhibitor of the acyl-lysine reader ENL/AF9 YEATS domain with IC50 of 0.05 and 0.07 uM, respectively.
TDI-11055 shows no inhibition of the YEATS domains of GAS41 and YEATS2 (IC50 > 100 μM), the other two YEATS domain-containing proteins.
TDI-11055 shows direct binding affinity to the ENL YEATS domain with Kd of 119 nM in isothermal titration calorimetry (ITC) assays.
TDI-11055 binds to and stabilizes endogenously expressed ENL but not GAS41 or YEATS2 in cells, binds directly to the acyl-binding site in ENL and engages with key acyl-recognizing residues.
TDI-11055 treatment led to a substantial displacement of ENL from target genes, including well-established leukemogenic genes in AML such as MYC and the HOXA cluster, TDI-11055 is a validated chemical tool for efficiently and specifically perturbing the chromatin reader function of ENL in living cells.
TDI-11055 inhibits the growth of MLL-r and NPM1-mutated leukemia cells in vitro (MV4;11 cell viability IC50=0.27 uM), decreases the expression of several key oncogenes in AML, including MYC, HOXA9/10, and MYB.
TDI-11055 impairs the clonogenic potential and induces differentiation of MLL-r and NPM1-mutated primary AML patient samples, blocks disease progression in models of MLL-r leukemia.
| M.Wt | 388.475 | |
| Formula | C22H24N6O | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(S)-1-methyl-N-(2-((2-methylpyrrolidin-1-yl)methyl)-1H-pyrrolo[3,2-c]pyridin-6-yl)-1H-indazole-5-carboxamide |
|
1. Yiman Liu, et al. Cancer Discov. 2022 Sep 2;CD-21-1307.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
